← back to search

Sharron Gargosky

Oncotherapeutics (United States) · ES
Area of research
Endocrinology, Diabetes and Metabolism · Oncology
Research interest
Research interests include Growth Hormone and Insulin-like Growth Factors, Immunotherapy and Immune Responses, CAR-T cell therapy research, and Cancer Immunotherapy and Biomarkers.
h-index
33
citations
3,806
works
117
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma
Clinical Cancer Research 2020cited by 141position: middledoi
Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients
Annals of Oncology 2020cited by 132position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Erica Browning · San Diego Composites (United States)2 papers (2020–2020)Adil Daud · UCSF Helen Diller Family Comprehensive Cancer Center2 papers (2020–2020)Donna Bannavong · San Diego Composites (United States)2 papers (2020–2020)Shailender Bhatia · University of Washington2 papers (2020–2020)Mai H. Le · The University of Texas Health Science Center2 papers (2020–2020)Carmen Ballesteros‐Merino · Providence Portland Medical Center2 papers (2020–2020)Bernard A. Fox · Portland VA Medical Center2 papers (2020–2020)Alain P. Algazi · UCSF Helen Diller Family Comprehensive Cancer Center2 papers (2020–2020)Lawrence Fong · Fred Hutch Cancer Center2 papers (2020–2020)Chris Twitty · General Atomics (United States)2 papers (2020–2020)Robert H. Pierce · Nabriva Therapeutics (Austria)2 papers (2020–2020)Katy K. Tsai · UCSF Helen Diller Family Comprehensive Cancer Center2 papers (2020–2020)Lauren P. Levine · University of California, San Francisco2 papers (2020–2020)Mikäel J. Pittet · University of Geneva1 papers (2020–2020)Reneta Talia · Eden Medical1 papers (2020–2020)Karl D. Lewis · Regeneron (United States)1 papers (2020–2020)Michael D. Rosenblum · University of California, San Francisco1 papers (2020–2020)Robert H.I. Andtbacka · HiFiBiO Therapeutics (United States)1 papers (2020–2020)Mauricio Borrero Franco · University of California, San Francisco1 papers (2020–2020)Arielle Oglesby · UCSF Helen Diller Family Comprehensive Cancer Center1 papers (2020–2020)